Butyrate Activates the WAF1/Cip1 Gene Promoter through Sp1 Sites in a p53-negative Human Colon Cancer Cell Line
Open Access
- 1 August 1997
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 272 (35) , 22199-22206
- https://doi.org/10.1074/jbc.272.35.22199
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- New functional activities for the p21 family of CDK inhibitors.Genes & Development, 1997
- p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrestCell, 1994
- p21 is a universal inhibitor of cyclin kinasesNature, 1993
- Isolation of a mitomycin-resistant human lung adenocarcinoma cell subline to investigate the modulation by sodium butyrate of cell growth and drug resistanceAnti-Cancer Drugs, 1993
- Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunitNature, 1993
- The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinasesCell, 1993
- Differentiating effect of sodium butyrate on human hepatoma cell lines PLC/PRF/5, HCC‐M and HCC‐TInternational Journal of Cancer, 1991
- Sodium butyrate induces differentiation in breast cancer cell lines expressing the estrogen receptorJournal of Cellular Physiology, 1988
- Short chain fatty acids in the human colon.Gut, 1981
- Butyric acid, a potent inducer of erythroid differentiation in cultured erythroleukemic cellsCell, 1975